{
    "clinical_study": {
        "@rank": "57173", 
        "arm_group": [
            {
                "arm_group_label": "Deep neuromuscular blockade", 
                "arm_group_type": "Experimental", 
                "description": "Deep neuromuscular blockade"
            }, 
            {
                "arm_group_label": "moderate neuromuscular blockade", 
                "arm_group_type": "Active Comparator", 
                "description": "moderate neuromuscular blockade"
            }
        ], 
        "brief_summary": {
            "textblock": "Intraocular pressure is significantly increase during robot-assisted laparoscopic radical\n      prostatectomy which is performed in a steep trendelenburg position at prolonged times of\n      pneumoperitoneum. Therefore investigators decided to evaluate the impacts of surgical\n      visibility through deep neuromuscular blockade on intraocular pressure in patients\n      undergoing Robot-Assisted Laparoscopic Radical Prostatectomy."
        }, 
        "brief_title": "The Impacts of Surgical Visibility Through Deep Neuromuscular Blockade on Intraocular Pressure in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Robot-Assisted Laparoscopic Radical Prostatectomy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. ASA class I-II\n\n          2. obtaining written informed consent from the parents\n\n          3. aged over 50 years who were undergoing robot- assisted laparoscopic prostatectomy\n\n        Exclusion Criteria:\n\n          1. eye surgery previously\n\n          2. unstable angina or congestive heart failure\n\n          3. concomitant eye disease (glaucoma, diabetic retinopathy, cataract, retinal\n             detachment)\n\n          4. high intraocular pressure over 30mmHg after screening test.\n\n          5. uncontrolled hypertension (diastolic bp>110mmHg)\n\n          6. coagulopathy\n\n          7. asthma\n\n          8. hepatic failure\n\n          9. renal failure(creatinine clearance < 30 ml/min)\n\n         10. drug hyperactivity\n\n         11. neurological or psychiatric illnesses\n\n         12. mental retardation\n\n         13. patients who can`t read the consent form due to illiterate or foreigner\n\n         14. previous malignant hyperthermia Hx\n\n         15. drug medication which interact with muscle relaxant (anti-convulsant, certain\n             antibiotics, magnesium etc)\n\n         16. BMI > 30kg/m2"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "68", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 30, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02109133", 
            "org_study_id": "4-2014-0058"
        }, 
        "intervention": [
            {
                "arm_group_label": "Deep neuromuscular blockade", 
                "description": "deep neuromuscular blockade using rocuronium and reverse with sugammadex", 
                "intervention_name": "deep neuromuscular blockade", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "moderate neuromuscular blockade", 
                "description": "moderate neuromuscular blockade using atracurium and reverse with neostigmine", 
                "intervention_name": "moderate neuromuscular blockade", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Deep neuromuscular blockade", 
                "intervention_name": "Rocuronium", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Deep neuromuscular blockade", 
                "intervention_name": "Sugammadex", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "moderate neuromuscular blockade", 
                "intervention_name": "Atracurium", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "moderate neuromuscular blockade", 
                "intervention_name": "Neostigmine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Atracurium", 
                "Rocuronium", 
                "Neostigmine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "deep neuromuscular blockade", 
            "intraocular pressure"
        ], 
        "lastchanged_date": "April 8, 2014", 
        "location": {
            "contact": {
                "email": "sjbai1@yuhs.ac", 
                "last_name": "Sun Jun Bai, MD", 
                "phone": "1-82-2-2228-2418"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "120-752"
                }, 
                "name": "Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "sjbai1@yuhs.ac", 
            "last_name": "Sun Jun Bai, MD", 
            "phone": "1-82-2-2228-2418"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "T0: Pre-induction T1: 5min after anesthesia induction T2: 5 min after establish pneumoperitoneum T3: 30min after steep trendelenburg position T4: 60min after steep trendelenburg position T5: 5min after returning to horizontal position T6: 5min after tracheal extubation T7: 30min after tracheal extubation T8: 60min after tracheal extubation", 
            "measure": "compare the influence of surgical visibility through deep neuromuscular blockade on intraocular pressure in patients undergoing Robot-Assisted Laparoscopic Radical Prostatectomy.", 
            "safety_issue": "No", 
            "time_frame": "within 1hour after tracheal extubation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02109133"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}